KRYSのPER（株価収益率）は？

Krystal Biotech Inc（KRYS）は現在PER 39.93倍で取引されています。

KRYSのROE（自己資本利益率）は？

Krystal Biotech IncのROEは17.77%です。

KRYSの配当利回りは？

Krystal Biotech Incの配当利回りは0.00%です。

KRYSの品質スコア（Quality Score）は？

当社のAIはKRYSの総合財務品質を100点中85点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

KRYSは今が買い時ですか？

当社AIのタイミングスコアは100点中55点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

KRYSはどのセクターに属しますか？

Krystal Biotech IncはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

KRYS (NASDAQ) 株価分析 | Krystal Biotech Inc

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-06 | FS: 2026-06-30)

KRYS AI Analysis Summary

Our AI summary for KRYS: Krystal Biotech Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 39.93, ROE of 17.77%, a dividend yield of 0.00%. Its financial Quality Score stands at 85/100 — fundamentals stronger than most of the market. The AI Timing Score is 55/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

KRYS

Krystal Biotech Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 89

USD 322.69

-3.09 (-0.95%) Day Change

Watchlist Portfolio Compare Chart

39.93

P/E

0.00

D/E

17.8%

ROE

16.1%

ROA

0.00%

Div Yield

0.18

PEG

KRYSTAL BIOTECH INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 322.69 Price -3.09 (-0.95%) Day Change	NEWS SCORE: 89

KRYS, ファンダメンタルスコアはvery good ( ファンダメンタル = 85) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

85 QUALITY

Signal: OUTPERFORM

Signal Description: Company financial health is Good

Reason: 平均ROEが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析

57%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.13 From 30 days period
News Score	89
Magic Formula Rank by ROA	1247
Magic Formula Rank by ROE	1247
Magic Formula Rank by ROIC	1199
Price	322.69
PBV / Sector	7.09 / 5.21
Earning Per Share	8.08

PE / Sector	39.93 / 21.00
PEG or PE/Growth / Sector	0.18 / 1.11 GREAT
Average 1M Daily Value	220.74 M GREAT
Average 1W Daily Value	175.22 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

68%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	54.82 / 95.56 GREAT
NPM Average (%) / Sector	39.93 / -1,676.77 GREAT
NPM Change Average (%) / Sector	N/A / 4,917.73
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	16.09 / 25.44 GOOD
ROA Average (%) / Sector	3.23 / -350.66
ROA Change Average (%) / Sector	128.36 / 5,110.09 GREAT
ROE (%) / Sector	17.77 / 3.07
ROE Average (%) / Sector	3.72 / 4.81
ROE Change Average (%) / Sector	137.46 / 2,068.02 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.02
Dividend Average (%) / Sector	N/A / 17.10
Dividend Change Average (%) / Sector	N/A / 0.98

登録情報

Analyze Date	2026-08-07 08:11:55
Symbol	KRYS
Name	KRYSTAL BIOTECH INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	29.60 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	9,642.71 / 9,672.56

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2100 Wharton Street, Pittsburgh, PA, United States, 15203

Phone: 412 586 5830

Website: https://www.krystalbio.com

Employees: 295

Sector: Healthcare >> Biotechnology

Description: Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.